LGALS3 and cancer: As a result, strategies ranging from the design and preparation of potent synthetic small molecule antagonists (i.e., glycomimetics) to large biologics from natural sources are being employed to target Gal3 for therapeutic intervention for a variety of cancers, fibrosis, and other diseases.